"There is nobody who wouldn't like to": understanding the motivations behind women's participation in a Phase I clinical trial for a subdermal HIV prevention implant in KwaZulu-Natal, South Africa
{{output}}
A novel long-acting HIV oral pre-exposure prophylaxis (PrEP) implant was first tested in a Phase I clinical trial in South Africa, and this study sought to understand motivations behind trial participants enrolment, highlighting considerations for recruitment ... ...
